Skip to search formSkip to main contentSkip to account menu

Ursofalk

Known as: Tramedico Brand of Ursodeoxycholic Acid, Provalis Brand of Ursodeoxycholic Acid, Orphan Brand of Ursodeoxycholic Acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence… 
2016
2016
This study, was established five groups of albino rats to determine the therapeutic effect of Curcuma longa and ursofalk against… 
Highly Cited
2014
Highly Cited
2014
ABSTRACT Objective: The objective is to present an update on the diagnosis and treatment of hypovita­minosis D, based on the most… 
Highly Cited
2014
Highly Cited
2014
OBJECTIVE The objective is to present an update on the diagnosis and treatment of hypovitaminosis D, based on the most recent… 
2006
2006
Intoxication with deoxycholic acid is accompanied by destruction of hepatocyte plasma membrane (increased serum alanine… 
2005
2005
Background:  Ursodeoxycholic acid is an approved therapy for hepatobiliary disorders but in infants and children compliance is… 
1997
1997
Bilirubin is a sensitive marker of toxic liver injury. Carbontetrachloride (CCl4) is used in some manufactures and laboratories… 
1992
1992
Ursodeoxycholic-acid (UDCA) was introduced to the clinical practice as an effective agent for the dissolution of gallstones. The…